Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICS
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This study examines the pharmacokinetic profile of Armstrong's proposed Epinephrine
Inhalation Aerosol USP, an HFA134a propelled Metered Dose Inhaler (MDI) (E004), using a
stable isotope deuterium-labeled epinephrine (epinephrine-d3) to differentiate the
administered drug from the endogenous epinephrine, in healthy male and female adult
volunteers.